Literature DB >> 7021152

Molecular properties of two mutant species of the elongation factor Tu.

P H Van der Meide, F J Duisterwinkel, J M De Graaf, B Kraal, L Bosch, J Douglass, T Blumenthal.   

Abstract

The molecular properties of two mutant species of the elongation factor Tu (EF-Tu), derived from either tuf A or tuf B, have been studied. One, designated EF-TuAR, is the product of a kirromycin-resistant tufA gene. The other designated EF-TuBO is a tuf B product and is present in a kirromycin-resistant mutant of Escherichia coli (LBE 2012) also harbouring the EF-TuAR species. EF-TuAR has been isolated in homogeneous form as a single gene product from the mutant strain LBE 2045, in which the tuf B gene has been inactivated by an insertion of the bacteriophage Mu. EF-TuBO has been isolated from LBE 2012 together with EF-TuAR in a 1:1 mixture. Fractionation of this mixture of DEAE-Sephadex A-50 resulted in an enrichment of EF-TuBO of about 80%. The properties of EF-TuAR and EF-TuBO have been compared to those of a kirromycin-sensitive species designated EF-TuAS, which was isolated from LBE 2045 by transduction of wild-type tuf A. We show here that all three EF-Tu species are fully competent to sustain polypeptide synthesis. All also appear to interact normally with guanine nucleotides and EF-Ts. Only in the presence of the antibiotic do the following differences appear. (a) Kirromycin causes EF-TuAS (wild-type tuf A gene product) to be retained on, and thus block, the ribosome. (b) EF-TuAR fails to bind the antibiotic and thus is capable of protein synthesis in its presence. (c) EF-TuBO fails to sustain polypeptide synthesis upon binding of kirromycin. It does not, however, block the ribosome, so the strain harbouring both this protein and EF-TuAR (LBE 2012) is kirromycin resistant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7021152     DOI: 10.1111/j.1432-1033.1981.tb06294.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

1.  The G222D mutation in elongation factor Tu inhibits the codon-induced conformational changes leading to GTPase activation on the ribosome.

Authors:  E Vorstenbosch; T Pape; M V Rodnina; B Kraal; W Wintermeyer
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

2.  The influence of different modifications of elongation factor Tu from Escherichia coli on ternary complex formation investigated by fluorescence spectroscopy.

Authors:  G Ott; J Jonák; I P Abrahams; M Sprinzl
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

3.  The isolation and mapping of EF-Tu mutations in Salmonella typhimurium.

Authors:  D Hughes
Journal:  Mol Gen Genet       Date:  1986-01

4.  Effects of elfamycins on elongation factor Tu from Escherichia coli and Staphylococcus aureus.

Authors:  C C Hall; J D Watkins; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

5.  The structural and functional basis for the kirromycin resistance of mutant EF-Tu species in Escherichia coli.

Authors:  J R Mesters; L A Zeef; R Hilgenfeld; J M de Graaf; B Kraal; L Bosch
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

6.  Specific alterations of the EF-Tu polypeptide chain considered in the light of its three-dimensional structure.

Authors:  F J Duisterwinkel; B Kraal; J M De Graaf; A Talens; L Bosch; G W Swart; A Parmeggiani; T F La Cour; J Nyborg; B F Clark
Journal:  EMBO J       Date:  1984-01       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.